Risk Factors Update Summary

• Added risk factors related to the Vaso Business Combination, including the need to comply with SEC filings. This may impact investor confidence.
• Uncertainties exist regarding completing the Vaso Business Combination by July 19, 2024, potentially leading to liquidation.
• Change in excise tax liability due to share redemptions, with $4,002,722 and $952,940 redeemed.
• Material weakness in internal controls identified, affecting financial reporting accuracy and timeliness.
• The Vaso Business Combination may not be completed on anticipated terms, leading to risks and uncertainties.
• Nasdaq non-compliance notifications and extensions granted, affecting continued listing requirements. Failure to comply may lead to delisting.
• Failure to complete the Vaso Business Combination may result in public stockholders losing their investment.
• Actions taken to regain Nasdaq compliance, including transferring Founder Shares and potential future transfers, to meet listing requirements.
• The Surviving Company post-merger may face significant negative financial impacts, affecting stock price.
• Detailed notifications from Nasdaq regarding non-compliance with listing rules, including deadlines for compliance plans and extensions granted.
• Restrictions in the Vaso Business Combination Agreement may hinder the Company from pursuing alternative business combinations.
• Conflicts of interest may arise due to the Sponsor's interests differing from those of other stakeholders.
• Increased financial requirements for Nasdaq listing, including a minimum bid price of $1.00 per share and stockholders' equity of at least $5.0 million.
• Potential going concern doubt due to $48,395 cash and $4,125,881 working capital deficit.
• Risks associated with potential delisting from Nasdaq, including limited market access, reduced visibility, and challenges in obtaining financing.
• Significant transaction and transition costs are expected in connection with the Vaso Business Combination.
• Potential consequences of delisting from Nasdaq, such as reduced liquidity, limited market quotations, and increased trading restrictions.